Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 15 de 15
Filtrer
1.
J Am Heart Assoc ; 13(3): e032153, 2024 Feb 06.
Article de Anglais | MEDLINE | ID: mdl-38293949

RÉSUMÉ

BACKGROUND: Atrial fibrillation (AF) is the most common type of arrhythmia worldwide and is associated with serious complications. This study investigated the metabolic biomarkers associated with AF and the differences in metabolomics and associated metabolic biomarkers between paroxysmal AF (AFPA) and persistent AF. METHODS AND RESULTS: Plasma samples were prospectively collected from patients with AF and patients in sinus rhythm with negative coronary angiography. The patients were divided into 3 groups: AFPA, persistent AF, and sinus rhythm (N=54). Metabolomics (n=36) using ultra-high-performance liquid chromatography mass spectrometry was used to detect differential metabolites that were validated in a new cohort (n=18). The validated metabolites from the validation phase were further analyzed by receiver operating characteristic. Among the 36 differential metabolites detected by omics assay, 4 were successfully validated with area under the curve >0.8 (P<0.05). Bioinformatics analysis confirmed the enrichment pathways of unsaturated fatty acid biosynthesis, glyoxylate and dicarboxylate metabolism, and carbon metabolism. Arachidonic acid was a potential biomarker of AFPA, glycolic acid and L-serine were biomarkers of AFPA and persistent AF, and palmitelaidic acid was a biomarker of AFPA. CONCLUSIONS: In this metabolomics study, we detected 36 differential metabolites in AF, and 4 were validated with high sensitivity and specificity. These differential metabolites are potential biomarkers for diagnosis and monitoring of disease course. This study therefore provides new insights into the precision diagnosis and management of AF.


Sujet(s)
Fibrillation auriculaire , Humains , Fibrillation auriculaire/complications , Marqueurs biologiques , Métabolomique/méthodes
2.
J Clin Nurs ; 33(3): 797-816, 2024 Mar.
Article de Anglais | MEDLINE | ID: mdl-38108237

RÉSUMÉ

AIMS: To analyse healthcare providers' (HCPs) experiences in sexual health care through the mixed-methods systematic review (MMSR). BACKGROUND: Sexual health for breast cancer survivors (BCSs) is becoming increasingly important as survivors live longer. HCPs are critical in providing sexual health care. DESIGN: A mixed-methods systematic review. METHODS: Literature searches were conducted in databases MEDLINE, CINAHL, Psychology & Behavioral Sciences Collection, Web of Science, Cochrane Library, Scopus, ClinicalTrials.gov and reference lists were searched from inception to 30 December 2022. Two independent reviewers extracted and analysed the data using the JBI guidelines for MMSR. RESULTS: After screening for 2849 citations, 19 studies were eligible for MMSR, involving 2068 HCPs. Most HCPs believe that sexual health care is their responsibility. However, sexual health was not adequately addressed. A lack of knowledge was the most significant barrier to providing sexual health care. Moreover, HCPs would like to acquire more knowledge and felt that current sexual healthcare training was inadequate. CONCLUSIONS: Findings suggest that HCPs did not frequently address sexual health in BCSs and that lack of knowledge was the most common barrier. Healthcare session administrators should allocate resources for sexual healthcare training that offer multiple formats, accessible content and convenience. They should also be multifaceted and proactive, meet the diverse needs of BCS at different stages and focus on effective communication. RELEVANCE TO CLINICAL PRACTICE: This study highlights the importance of addressing sexual health in BCSs and the need for HCPs to receive training in this area. Training should be multifaceted, proactive and meet the diverse needs of BCSs at different stages, with a focus on effective communication. By addressing this issue, HCPs will be better equipped to support the sexual health needs of BCSs, ultimately improving their overall well-being and quality of life. PROSPERO Registration Number: CRD42022327018 (https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=327018).


Sujet(s)
Tumeurs du sein , Survivants du cancer , Personnel de santé , Santé sexuelle , Humains , Tumeurs du sein/psychologie , Survivants du cancer/psychologie , Femelle , Personnel de santé/psychologie , Adulte , Attitude du personnel soignant , Adulte d'âge moyen
3.
Hu Li Za Zhi ; 70(3): 75-84, 2023 Jun.
Article de Chinois | MEDLINE | ID: mdl-37259653

RÉSUMÉ

Systematic reviews provide important empirical evidence for healthcare providers to make the best clinical decisions. While qualitative research provides subjective information on the human experience, quantitative research may be used to provide quantified evaluations of interventions. To overcome the lack of objectivity in qualitative research and of context considerations in quantitative research, recent efforts have focused on developing mixed-method approaches that combine meta-analysis (quantitative systematic reviews) and meta-synthesis (qualitative systematic reviews). This new idea may help conceptualize studied phenomena more thoroughly. However, the typology remains inconsistent and the currently proposed approaches lack unified guidance and principles. In this paper, "mixed methods systematic review", a term promoted by the Joanna Briggs Institute, is used to indicate the newly developed systematic review. The use of systematic review in quantitative research and in qualitative research and the use of mixed methods systematic review are introduced chronologically, with an emphasis on procedures, examples, and quality appraisal tools. The concepts and concrete procedures for integrating results from different research method are presented for researchers and healthcare providers to allow them to better understand this approach and explore related phenomena more thoroughly.


Sujet(s)
Plan de recherche , Revues systématiques comme sujet , Humains , Personnel de santé , Recherche qualitative
6.
BMC Cardiovasc Disord ; 21(1): 258, 2021 05 26.
Article de Anglais | MEDLINE | ID: mdl-34039268

RÉSUMÉ

BACKGROUND: Limited data were available on the current trends in optimal medical therapy (OMT) after PCI and its influence on clinical outcomes in China. We aimed to evaluate the utilization and impact of OMT on the main adverse cardiovascular and cerebrovascular events (MACCEs) in post-PCI patients and analyzed the factors predictive of OMT after discharge. METHODS: We collected data from 3812 individuals from 2016.10 to 2017.09 at TEDA International Cardiovascular Hospital. They were classified into an OMT group and a non-OMT group according to their OMT status, which was defined as the combination of dual antiplatelet therapy, statins, ß-blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers after PCI. Multivariable Cox regression models were developed to assess the association between OMT and MACCEs, defined as all-cause mortality, nonfatal myocardial infarction, stroke, and target vessel revascularization. A logistic regression model was established to analyze the factors predictive of OMT. RESULTS: Our results revealed that the proportion of patients receiving OMT and its component drugs decreased over time. A total of 36.0% of patients were still adherent to OMT at the end of follow-up. Binary logistic regression analysis revealed that baseline OMT (P < 0.001, OR = 52.868) was the strongest predictor of OMT after PCI. The Cox hazard model suggested that smoking after PCI was associated with the 1-year risk of MACCE (P = 0.001, HR = 2.060, 95% CI 1.346-3.151), while OMT (P = 0.001, HR = 0.486, 95% CI 0.312-0.756) was an independent protective factor against postoperative MACCEs. CONCLUSIONS: There was still a gap between OMT utilization after PCI and the recommendations in the evidence-based guidelines. Sociodemographic and clinical factors influence the application of OMT. The management of OMT and smoking cessation after PCI should be emphasized.


Sujet(s)
Agents cardiovasculaires/usage thérapeutique , Maladie coronarienne/thérapie , Intervention coronarienne percutanée/tendances , Types de pratiques des médecins/tendances , Sujet âgé , Agents cardiovasculaires/effets indésirables , Chine/épidémiologie , Comorbidité , Maladie coronarienne/diagnostic , Maladie coronarienne/mortalité , Utilisation médicament/tendances , Femelle , Humains , Mâle , Adhésion au traitement médicamenteux , Adulte d'âge moyen , Intervention coronarienne percutanée/effets indésirables , Intervention coronarienne percutanée/mortalité , Études prospectives , Appréciation des risques , Facteurs de risque , Fumer/effets indésirables , Fumer/mortalité , Arrêter de fumer , Facteurs temps , Résultat thérapeutique
7.
Angiology ; 71(2): 183-188, 2020 02.
Article de Anglais | MEDLINE | ID: mdl-30987432

RÉSUMÉ

We investigated the preventive effect of nicorandil on contrast-induced nephropathy (CIN) in patients with moderate renal insufficiency undergoing percutaneous coronary intervention (PCI). A total of 250 patients with a creatinine clearance (crCl) ≤60 mL/min undergoing PCI were randomly assigned to either a nicorandil group (nicorandil 10 mg 3 times/d and hydration; n = 125) or a control group (hydration only; n = 125). The first end point was the incidence of CIN defined as an increase in serum creatinine (Scr) levels by ≥0.5 mg/dL or ≥25% within 72 hours after exposure to the contrast medium. The secondary end points were (1) changes in Scr, blood urea nitrogen, and crCl and (2) the incidence of major adverse events during hospitalization. The incidence of CIN was 1.6% (2/125) in the nicorandil group and 9.6% (12/125) in the control group (P = .011). There was no obvious difference in the incidence of major adverse events during hospitalization between the nicorandil and the control group (4.0% vs 4.8%, P = 1.000). Multivariate logistic regression analysis showed that nicorandil was a protective factor for CIN (odds ratios = 0.126, 95% confidence interval: -19.996 to -0.932, P = .012). Prophylactic administration of nicorandil may prevent against CIN in patients with moderate renal insufficiency undergoing PCI.


Sujet(s)
Maladies du rein/induit chimiquement , Maladies du rein/prévention et contrôle , Nicorandil/usage thérapeutique , Intervention coronarienne percutanée , Insuffisance rénale/complications , Sujet âgé , Produits de contraste/effets indésirables , Femelle , Humains , Mâle , Indice de gravité de la maladie
9.
Angiology ; 69(5): 393-399, 2018 May.
Article de Anglais | MEDLINE | ID: mdl-29073785

RÉSUMÉ

We investigated the preventive effect of alprostadil on contrast-induced nephropathy (CIN) in patients with renal insufficiency undergoing percutaneous coronary intervention (PCI). A total of 300 patients with creatinine clearance (crCl) ≤60 mL/min undergoing PCI were randomly assigned to alprostadil or a control group. The primary end point was the incidence of CIN defined as an increase in serum creatinine (Scr) levels by ≥0.5 mg/dL or≥ 25% after administration of the contrast media within 72 hours. The secondary end points were (1) changes in Scr and crCl within 72 hours and (2) the incidence of major adverse events during hospitalization. The incidence of CIN was 2.7% (4/150) in the alprostadil group, and 8.7% (13/150) in the control group (χ2 = 5.05, P = .043).There was no difference regarding the incidence of major adverse events during hospitalization between the alprostadil group and control groups (2.7% vs 4.0%, P = .750). Multivariate logistic regression analysis showed that alprostadil was an independent protective factor for CIN (odds ratio = 0.136, 95% confidence interval: 0.020-0.944, P = .044). Prophylactic administration of alprostadil may prevent CIN in patients with renal insufficiency undergoing PCI.


Sujet(s)
Alprostadil/usage thérapeutique , Produits de contraste/effets indésirables , Intervention coronarienne percutanée/effets indésirables , Insuffisance rénale/induit chimiquement , Insuffisance rénale/épidémiologie , Vasodilatateurs/usage thérapeutique , Sujet âgé , Maladie des artères coronaires/complications , Maladie des artères coronaires/chirurgie , Créatinine/sang , Femelle , Hospitalisation , Humains , Incidence , Modèles logistiques , Mâle , Adulte d'âge moyen , Insuffisance rénale/diagnostic
10.
Hu Li Za Zhi ; 64(4): 97-103, 2017 Aug.
Article de Chinois | MEDLINE | ID: mdl-28762230

RÉSUMÉ

Happiness, an important factor in maintaining health, not only enhances the abilities of self-control, self-regulation, and coping but also promotes mental health. Mindfulness therapy has been increasingly used in recent years. Therefore, the purpose of the present article is to introduce the concepts of mindfulness and to describe the relationship between mindfulness and happiness. Further, we provide brief introductions to mindfulness-based stress reduction and mindfulness cognitive therapy as well as present the current evidence related to the effects of mindfulness programs and therapies in clinical patient care. The information in the present article may be referenced and used by nurses in patient care and may be referenced by health professionals to promote their own mental health in order to maintain optimal fitness for providing high-quality patient care.


Sujet(s)
Bonheur , Santé mentale , Pleine conscience , Humains
11.
Chin Med J (Engl) ; 130(12): 1411-1417, 2017 Jun 20.
Article de Anglais | MEDLINE | ID: mdl-28584202

RÉSUMÉ

BACKGROUND: Atrial AutoCapture™ (ACap™) was a new technological development that confirmed atrial capture by analyzing evoked response (ER) with a new method - paced depolarization integral ER detection - and optimized energy output to changes in the stimulation threshold. The purpose of this study was to evaluate the clinical performance of ACap™ function. METHODS: This was a prospective, observational, nonrandomized two-center study. Between November 2008 and August 2014, 102 patients were enrolled from two different institutions. Data were collected by case report forms at enrollment, hospital discharge, and in-office follow-ups scheduled at 1, 2, 3, 6, and 12 months postimplantation. RESULTS: Ambulatory ACap™ function started to become available for 20.6% of patients at 1 day, then progressed to 30.4% at 7 days, 38.6% at 1 month, 41.6% at 2 months, 47.5% at 3 months, 53.5% at 6 months, and 63.4% at 1 year. The cause of the unsuccessful attempts to perform ACap™ threshold was ER/polarization <2:1. Availability for SD, BND, and HOCM indications had shown better results than AVB indication. For SD indication cases, feasibility was significantly better for SD with paroxysmal atrial fibrillation (pAF) than SD without pAF (78.4% vs. 35.0% at 1 year, n = 71, P< 0.001). At each stage of the clinical follow-ups, there had been a strict correlation between ACap™ measurements and those conducted manually with P 0.001 (n = 299). CONCLUSIONS: It has been concluded that ACap™ function was safe and effective to confirm atrial threshold and reduce energy output automatically. ACap™ function is unavailable for some patients at early stages of the implantation; however, availability has been progressively increasing during follow-up.


Sujet(s)
Entraînement électrosystolique/méthodes , Pacemaker , Sujet âgé , Algorithmes , Fibrillation auriculaire/thérapie , Électrodes implantées , Femelle , Atrium du coeur/physiopathologie , Humains , Mâle , Adulte d'âge moyen , Études prospectives , Résultat thérapeutique
12.
Metab Syndr Relat Disord ; 11(2): 109-14, 2013 Apr.
Article de Anglais | MEDLINE | ID: mdl-23350809

RÉSUMÉ

BACKGROUND: Carotid atherosclerosis should not be neglected as a cause for stroke in China, despite its low prevalence. This study was performed to evaluate the association between ultrasonographic markers for different stages of carotid atherosclerosis and metabolic syndrome. METHODS: This was a community-based study in Hong Kong. Metabolic syndrome was defined as having three or more of the following conditions or receiving specific treatment for these conditions: Abdominal obesity, elevated triglycerides, low high-density lipoprotein cholesterol, hypertension, and impaired fasting blood glucose. All subjects underwent carotid duplex ultrasonography. Mean carotid intima media thickness (CIMT) of bilateral common carotid arteries was used as the CIMT value for a single subject. CIMT within the 4(th) quartile was regarded as increased CIMT. Carotid plaque was defined as a focal CIMT of >1.5 mm. A carotid plaque obstructing ≥50% of vessel lumen was considered as carotid stenosis. RESULTS: A total of 653 subjects (mean age 55.1±10.4; 47.2% male) were recruited. Metabolic syndrome was found in 188 (28.8%) subjects (30.8% in males and 27.0% in females). Mean CIMT was 0.74±0.12 mm. Increased CIMT, carotid plaque, and carotid stenosis were detected in 163 (25.0%), 95 (14.5%), and 6 (1.4%) subjects, respectively. In multivariate linear regression, CIMT significantly increased with increasing numbers of metabolic syndrome components (P<0.001). In multivariate logistic regression analysis, metabolic syndrome was independently associated with increased CIMT [odds ratio (OR) 1.17; 95% confidence interval (CI) 1.11-2.64; P=0.014), but not presence of carotid plaque (OR 1.50; 95% CI 0.92-2.46; P=0.108). CONCLUSIONS: Metabolic syndrome may be independently associated with the early stage but not the later and advanced stages of carotid atherosclerosis in community residents in China.


Sujet(s)
Artériopathies carotidiennes/complications , Artériopathies carotidiennes/diagnostic , Syndrome métabolique X/complications , Syndrome métabolique X/diagnostic , Artères carotides/imagerie diagnostique , Artères carotides/anatomopathologie , Artériopathies carotidiennes/épidémiologie , Épaisseur intima-média carotidienne , Sténose carotidienne/anatomopathologie , Femelle , Hong Kong/épidémiologie , Humains , Mâle , Syndrome métabolique X/épidémiologie , Adulte d'âge moyen , Analyse multifactorielle , Odds ratio , Prévalence , Études prospectives , Facteurs de risque , Facteurs sexuels
13.
Int J Stroke ; 8(8): 663-8, 2013 Dec.
Article de Anglais | MEDLINE | ID: mdl-22883712

RÉSUMÉ

BACKGROUND: Dual antiplatelet therapy with clopidogrel and aspirin reduces the presence and number of microembolic signals in patients with large artery disease. However, whether it is effective in patients with intracranial disease alone remains uncertain. We performed a subgroup analysis of the The CLopidogrel plus Aspirin for Infarction Reduction (CLAIR in acute stroke or transient ischemic attack patients with large artery stenosis and microembolic signals) study of only patients with intracranial occlusive disease, excluding those with extra cranial disease. METHODS: CLAIR was a randomized-controlled, open-label, multicenter clinical trial with blinded outcome evaluation, which recruited patients with symptoms of ischemic stroke or transient ischemic attack within seven-days of onset, with large artery stenosis verified by transcranial Doppler and carotid ultrasound, and with microembolic signals detected by transcranial Doppler recording. All patients were randomized to receive clopidogrel plus aspirin daily for seven-days (dual treatment), or aspirin alone for seven-days (monotherapy). Repeated transcranial Doppler recordings for microembolic signals were made on day one, two, and seven. This subgroup study only analyzed the patients with purely intracranial large artery disease and excluded those with extra cranial stenosis. RESULTS: There were 70 patients recruited with purely intracranial stenosis, 34 in the dual treatment group and 36 in the monotherapy group. The proportion of the patients with positive emboli at day seven in the dual treatment group was significantly lower than that in the monotherapy group (relative risk reduction 56·5%, 95% confidence interval 2·5-80·6; P = 0·029). The number of emboli in the dual treatment group decreased significantly at day two (P = 0·043) and day seven (P = 0·018) compared with the monotherapy group. After adjustment for the number of emboli at day one, the effect of dual treatment was still significant for the reduction of presence (relative risk reduction 56·0%; 95% confidence interval 5·4-79·6; P = 0·036) and number (adjusted mean difference -0·9; 95% confidence interval -1·5 to -0·3; P = 0·004) of positive emboli at day seven. CONCLUSIONS: Dual treatment with clopidogrel and aspirin for seven-days is more effective than aspirin alone to reduce microembolic signals in patients with intracranial arterial stenosis.


Sujet(s)
Angiopathies intracrâniennes/complications , Angiopathies intracrâniennes/traitement médicamenteux , Antiagrégants plaquettaires/administration et posologie , Accident vasculaire cérébral/complications , Accident vasculaire cérébral/traitement médicamenteux , Acide acétylsalicylique/administration et posologie , Angiopathies intracrâniennes/imagerie diagnostique , Clopidogrel , Sténose pathologique/complications , Sténose pathologique/imagerie diagnostique , Sténose pathologique/traitement médicamenteux , Association de médicaments , Femelle , Humains , Mâle , Adulte d'âge moyen , Accident vasculaire cérébral/imagerie diagnostique , Ticlopidine/administration et posologie , Ticlopidine/analogues et dérivés , Échographie-doppler transcrânienne
14.
Stroke ; 44(1): 68-72, 2013 Jan.
Article de Anglais | MEDLINE | ID: mdl-23168454

RÉSUMÉ

BACKGROUND AND PURPOSE: Large artery intracranial occlusive disease (LAICOD) is a predominant cause of ischemic stroke in China. Carotid intima-media thickness (CIMT) and presence of carotid plaque are also related to subsequent ischemic stroke. However, the correlation between these and LAICOD is less clear. METHODS: This was a community-based cross-sectional study. All subjects underwent carotid duplex ultrasonography and transcranial Doppler. Mean CIMT value of bilateral common carotid arteries was used. Plaque was defined as a focal CIMT of >1.5 mm. LAICOD in transcranial Doppler was defined by peak systolic velocity and age, and presence of turbulence or musical sound was also considered. RESULTS: For the 537 subjects studied (mean age, 54.7±10.1 years; 46.9% males), mean CIMT was 0.74±0.12 mm, with the 75th percentile of 0.80 mm. CIMT ≥1.0 mm was identified in 13 subjects (2.4%). Plaques were detected in 79 subjects (14.7%). Compared with those without LAICOD, the 48 subjects (8.9%) with LAICOD had greater CIMTs (0.77±0.09 versus 0.73±0.12 mm; P=0.044), more with CIMT of higher quartiles (P=0.007), and more with carotid plaques (25.0% versus 13.7%; P=0.035). However, after adjusting for confounding factors, CIMT and presence of carotid plaque were not significantly associated with LAICOD. CONCLUSIONS: The results suggest that CIMT and presence of carotid plaque probably are not independently correlated with LAICOD in Chinese community residents, which supported the existence of pathologic and pathophysiologic differences in atherogenesis of intra- and extracranial arteries.


Sujet(s)
Épaisseur intima-média carotidienne , Artériopathies intracrâniennes/épidémiologie , Artériopathies intracrâniennes/anatomopathologie , Plaque d'athérosclérose/épidémiologie , Plaque d'athérosclérose/anatomopathologie , Adulte , Sujet âgé , Épaisseur intima-média carotidienne/effets indésirables , Chine/épidémiologie , Études de cohortes , Études transversales , Femelle , Humains , Mâle , Adulte d'âge moyen , Études prospectives
15.
Stroke ; 41(2): 383-4, 2010 Feb.
Article de Anglais | MEDLINE | ID: mdl-20035074

RÉSUMÉ

BACKGROUND AND PURPOSE: An ethnic extraintracranial difference in atherosclerosis has been well reported, whereas the potential mechanism remains unclear. We aimed to investigate neurovascular coupling in healthy whites and Asians. METHODS: Twenty volunteers of each ethnicity were recruited to perform a functional transcranial Doppler examination with standardized checkerboard patterns as visual stimulation (3 x 4, 6 x 8, and 12 x 16 checks subtending a visual field section of 18 degrees x 24 degrees , flicker rate 1 Hz). Hemodynamic responses in both posterior cerebral arteries were evaluated with a control system approach. RESULTS: The rate time, that is, the initial speed of flow velocity adaptation, was significantly lower in Asians leading to an approximately 2-second delayed hemodynamic adaptation. The other hemodynamic parameters and the dependency of hemodynamic responses in regard to the complexity degree of the stimulus were similar between groups. CONCLUSIONS: The constellation suggests a greater initial mismatch between functionally increased metabolic demand of neurons and adjusted cerebral blood flow in Asians.


Sujet(s)
Encéphale/métabolisme , Circulation cérébrovasculaire/physiologie , Artère cérébrale postérieure/imagerie diagnostique , Artère cérébrale postérieure/physiologie , , Adaptation physiologique/physiologie , Adulte , Asiatiques , Encéphale/vascularisation , Angiopathies intracrâniennes/ethnologie , Angiopathies intracrâniennes/génétique , Angiopathies intracrâniennes/physiopathologie , Métabolisme énergétique/physiologie , Femelle , Prédisposition génétique à une maladie/ethnologie , Hémodynamique , Humains , Mâle , Tests neuropsychologiques , Stimulation lumineuse , Projets pilotes , Temps de réaction/physiologie , Échographie-doppler transcrânienne , , Jeune adulte
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE